共查询到20条相似文献，搜索用时 218 毫秒
1.
病毒在静水压力50、200、250、300、350MPa灭活时间分别为60、50、30、20、20min,结果表明静水压力处理病毒颗粒体积缩小,免疫原性没有破坏;压力越高病毒失活越快,低压力长时间与高压力短时间灭活病毒的效果相同,以传统灭活制备的疫苗为对照,研究静水压技术新城疫病毒灭活工艺制备油乳剂疫苗的免疫原性。 相似文献
2.
水貂犬瘟热CDV_3疫苗株基因组序列测定及H基因遗传稳定性分析 总被引：1，自引：0，他引：1
对水貂犬瘟热CDV3疫苗株基因组进行全序列测定与分析,以阐明该疫苗株的来源亲本毒株,基因特征及H基因遗传稳定性。将CDV3疫苗株基因组cDNA分9个重叠片段进行RT-PCR并克隆入pMD 18-T载体中,测定全长cDNA序列。并与CDV野毒参考株和疫苗株N、F和H基因氨基酸序列比对分析其基因变异情况。通过对CDV3疫苗株6个不同生产批次(Vero细胞培养代次)H基因序列测定以分析毒株的分子遗传稳定性。基因序列分析结果表明:CDV3疫苗株基因组全长15 690 bp,与CDV野毒株基因组同源性较低(93.0%~95.3%)。H基因核苷酸和氨基酸序列与Lederle疫苗株(EF418783)同源性最高,分别为99.6%和98.7%。而6个不同培养代次CDV3疫苗株H基因氨基酸序列无任何差异。由此证实CDV3疫苗株的亲本毒株与Lederle疫苗株有着最密切关系,不同培养代次的CDV3疫苗株H基因具有较高的遗传稳定性。 相似文献
3.
为建立一种快速检测犬瘟热病毒(CDV)、犬细小病毒(CPV)、犬腺病毒Ⅱ型(CAV-2)和犬副流感病毒(CPIV)的多重PCR方法,参照Gen Bank中的相关病毒基因序列,分别设计了4对引物,用于特异性扩增CDV H基因、CPV VP2基因、CAV-2 E3基因和CPIV NP基因上的目的片段。通过优化反应条件,建立了同时扩增CDV(410 bp)、CPV(253 bp)、CVA-2(655 bp)和CPIV(868 bp)的多重PCR方法。利用建立的多重PCR方法,对CDV、CPV、CAV-2、CPIV、CDV+CPV+CAV-2+CPIV和犬冠状病毒(CCV)的DNA或c DNA模板进行扩增,发现该方法的特异性良好。利用建立的多重PCR方法与单一PCR方法进行敏感性比较,发现两者敏感性相差10倍,证明多重PCR方法敏感性良好。利用该方法对从北京市采集的30份犬病料样品进行检测,发现CDV阳性率为63.33%(19/30)、CPV阳性率为33.33%(10/30)、CAV-2阳性率为6.66%(2/30)、CPIV阳性率为0(0/30)。检测结果证明建立的多重PCR方法可用于临床诊断。 相似文献
4.
应用RT-PCR技术扩增出犬瘟热病毒（CDV）核衣壳（N）蛋白基因的高度保守序列，将其克隆至质粒pMD18-T中，获得了重组质粒pMD18-T-N。将N基因的目的片段克隆到表达载体pGEX-4T-1中谷胱甘肽转移酶（GST）基因的下游，并将该重组质粒转化大肠杆菌BL21株，经IPTG诱导，N基因融合蛋白获得了高效表达。SDS-PAGE电泳和Western—blot分析结果显示，表达产物的分子质量为55ku，与CDV标准阳性血清呈阳性反应。表明，大肠杆菌表达的CDVN蛋白在免疫原性上与天然N蛋白具有一定的相似性，可作为诊断用抗原。 相似文献
5.
犬瘟热病毒OP株囊膜糖蛋白H基因的克隆与表达 总被引：7，自引：1，他引：6
根据发表的犬瘟热病毒OP－CDV毒株序列设计两对引物，以犬瘟热病毒OP－CDV株感染Vero细胞收获病毒提取的RNA为模板，做RT－PCR扩增出H基因的5'端和3' 端大小为945bp、904bp的两个片段，两片段部分重叠，覆盖了H基因的全部编码序列。将PCR产物按正确的阅读框架定向克隆进pGEX-6P-1载体中谷胱甘肽－S－转移酶（GST）基因的下游，将重组质粒转化进宿主菌BL21中，在37℃ 1.0mM IRTG诱导下，H基因分段获得了良好的表达，表达产物经聚丙烯酰胺凝胶电泳鉴定，确定其表达的融合蛋白质大小分别为59kDa、58kDa，将表达产物回收后混合免疫小鼠。IFA显示免疫小鼠血清能与病毒感染细胞呈现特异反应，表明体外表达H基因保留了天然蛋白部分抗原性。 相似文献
6.
为研究犬瘟热病毒（canine distemper virus,CDV） V蛋白的功能,将CDV V基因片段与pGEX-6P-1载体连接,构建pGEX-6P-1-CDV-V重组表达质粒,通过原核表达系统表达了V蛋白,并将纯化的V蛋白免疫BALB/c小鼠,制备阳性血清。同时,将CDV V基因片段与pcDNA3.1载体连接,构建pcDNA3.1-CDV-V重组表达质粒,经转染Vero细胞后,用激光共聚焦技术确定V蛋白在真核细胞中的分布及亚细胞定位。结果显示,成功表达了V蛋白,并制备了阳性血清。重组质粒pcDNA3.1-CDV-V在外源真核细胞Vero中获得了表达,表达蛋白主要聚集于细胞质。本试验结果为进行CDV V蛋白的功能研究奠定了基础。 相似文献
7.
犬瘟热病毒小熊猫株H、F和N基因的克隆及表达 总被引：4，自引：0，他引：4
根据GenBank中发表的犬瘟热病毒（CDV）的核苷酸序列，设计并合成了扩增CDVH、F和N基因的3对引物，经RT—PCR分别扩增获得了CDV小熊猫株（LP株）H、F和N基因，并对H、F及N基因进行了克隆和序列测定。序列分析表明，CDV LP株属于强毒谱系，与CDV流行株的亲缘关系近．H基因含有较多潜在的糖基化位点．F和N基因相对比较保守。将CDV LP株H、F和N基因克隆入真核表达栽体pVAX1的CMV启动子下游，构建了CDV基因疫苗表达载体pVAXLPH、pVAXLPF、pVAXLPN，体外转染BHK-21细胞．用间接ELISA方法检测到目的蛋白的表达。用构建的3个表达质粒免疫小鼠，从小鼠血清中检测到了抗CDV抗体．初步证实用CDVH、F和N基因作为核酸疫苗免疫动物，可以激活机体的免疫应答。 相似文献
8.
根据发表的犬瘟热病毒（CDV）参考株Ondetstepoort的序列设计一对引物,以CDV感染的Vero细胞总RNA为模板,经RT-PCR扩增得到549bpDNA片段,将该片段以正确的阅读框架定向克隆于pGEX-4T-1中,然后将重组质粒转化宿主菌Rosetta^TM,在37℃、1．0mmol／LIPTG诱导下外源基因获得良好表达。经SDS．PAGE鉴定,表达的融合蛋白约46ku,与预期值一致。Westernblot试验显示,CDV免疫的小鼠血清可特异的识别该重组蛋白,表明该重组蛋白具有一定的免疫原性。 相似文献
9.
为了建立一种快速诊断犬瘟热病毒、犬细小病毒和犬副流感病毒的多重PCR方法,参照GenBank中的犬瘟热病毒(CDV)、犬细小病毒(CPV)、犬副流感病毒(CPIV)基因序列,设计了3对引物分别用于特异扩增犬瘟热病毒F基因、犬细小病毒VP2基因和犬副流感病毒F基因上的目的片段.通过优化反应条件,建立同时扩增CDV(740 bp)、CPV(419 bp)和CPIV(559 bp)的多重PCR方法.结果表明特异性和敏感性良好,对CDV、CPV、CPIV3种病毒的最低核酸检测量为1 ng/μL.临床样品的多重PCR检测结果表明,建立的多重PCR方法能够对CDV、CPV、CPIV单个感染或混合感染的临床样品进行快速鉴别诊断. 相似文献
10.
根据已发表的犬瘟热病毒(Canine distemper virus,CDV)Onderstepoort株序列设计1对引物,RT-PCR法扩增出约1 000 bp的融合蛋白基因片段,通过T-A克隆技术,将PCR产物克隆至pMD18-T载体。序列分析表明CDV蓝狐分离株F蛋白基因片段由1 044 bp组成,编码348个氨基酸,与其它CDV25259株、2544-Han95株、A75-17株、DOGDK91C株、5804P株、ONP株、PDV-2株核苷酸序列同源性分别为94.5%、94.1%、94.7%、94.2%、94.2%、97.6%和94.9%;氨基酸序列的同源性分别为98.6%、97.1%、98.0%、98.0%、98.3%、97.7%和98.6%;与其它CDV毒株相比,蓝狐分离株存在核苷酸缺失突变(1 030位～1 038位)和氨基酸缺失突变(344位～348位)。 相似文献
11.
犬瘟热病毒高压灭活疫苗的制备与应用 总被引：3，自引：0，他引：3
本试验用静水压高压灭活的方法对ＣＤＶ进行灭活,并加入蜂胶佐剂制备犬瘟热病毒高压灭活疫苗。将此灭活疫苗免疫接种ＣＤＶ易感犬,同时以用福尔马林灭活的犬瘟热病毒灭活疫功为对照,检测结果表明：犬瘟热病毒高压灭活疫苗安全、可靠,其诱导试验犬所产生中和抗体的能力明显高于该病毒的福尔马林灭活苗,临床应用证明该疫苗对犬的保护率达８９％。 相似文献
12.
犬瘟热的诊断及其预防免疫的研究进展 总被引：36，自引：7，他引：29
本文对犬瘟热（CD）的诊断、预防免疫和免疫失败的影响因素及犬瘟热病毒（CDV）的宿主范围进行了综述。CDV不仅感染陆生食肉动物，而且也感染水生食肉动物，并且其宿主范围还在不断扩大。CDV感染主要采用病毒分离、特异性病毒抗原或特异性核酸检测等方法确诊。疫苗包括灭活的CDV疫苗、麻疹病毒（MV）异源苗及CDV弱毒活苗。疫苗接种犬的免疫反应主要取决于毒株特性及犬的应答能力，只有弱毒活苗能诱导产生持久而坚强的保护力。尽管多年来CDV弱毒活苗的使用控制了CD的发生，但最近免疫过的犬发生CD的病例并不少见。分析免疫失败的原因，主要是母源抗体干扰、疫苗质量差、其它病毒的免疫抑制以及CDV流行株可能发生了变异等因素的影响。 相似文献
13.
J P Hoover C A Baldwin C E Rupprecht 《Journal of the American Veterinary Medical Association》1989,194(2):234-238
Nine unrelated 12-week-old naive domestic ferrets (Mustela putorius furo) were used to evaluate the serologic responses to commercial canine distemper virus (CDV) and rabies virus (RV) vaccines. Five of the ferrets (group 1) were inoculated 3 times at 2-week intervals with a multivalent modified-live virus vaccine of canine cell-line origin, containing CDV and an inactivated RV vaccine. Four of the ferrets (group 2) were inoculated once with the multivalent modified-live virus vaccine containing CDV and were not inoculated with the RV vaccine. Both group-1 and group-2 ferrets seroconverted to the CDV component of the vaccine. Group-1 ferrets also seroconverted after RV vaccination and maintained serum antibody titers to both CDV and RV for at least 7 months. Domestic ferret sera were found to have IgG epitopes similar to sera of domestic dogs and cats. Domestic ferret sera did not contain antibodies to feline coronavirus or FeLV antigens. 相似文献
14.
Griot-Wenk ME Cherpillod P Koch A Zurbriggen R Bruckner L Wittek R Zurbriggen A 《Journal of veterinary medicine. A, Physiology, pathology, clinical medicine》2001,48(5):295-302
This study compared the humoral immune response against the nucleocapsid-(N) protein of canine distemper virus (CDV) of dogs vaccinated with a multivalent vaccine against parvo-, adeno-, and parainfluenza virus and leptospira combined with either the attenuated CDV Onderstepoort strain (n = 15) or an expression plasmid containing the N-gene of CDV (n = 30). The vaccinations were applied intramuscularly three times at 2-week intervals beginning at the age of 6 weeks. None of the pre-immune sera recognized the recombinant N-protein, confirming the lack of maternal antibodies at this age. Immunization with DNA vaccine for CDV resulted in positive serum N-specific IgG response. However, their IgG (and IgA) titres were lower than those of CDV-vaccinated dogs. Likewise, DNA-vaccinated dogs did not show an IgM peak. There was no increase in N-specific serum IgE titres in either group. Serum titres to the other multivalent vaccine components were similar in both groups. 相似文献
15.
Comparative analyses of canine distemper viral isolates from clinical cases of canine distemper in vaccinated dogs 总被引：10，自引：0，他引：10
Lan NT Yamaguchi R Inomata A Furuya Y Uchida K Sugano S Tateyama S 《Veterinary microbiology》2006,115(1-3):32-42
Sequence and phylogenetic analyses of three isolates of canine distemper virus (CDV) isolated from three dogs with a vaccination history were compared with the same analyses of vaccine virus isolated from a vaccine used for dogs. The three dogs showed clinical signs of a recent major type of CD in Japan, including oculonasal discharge and diarrhea, and pathological findings including non-suppurative encephalitis, pneumonia, mild gastroenteritis and lymphoid depletion. Inclusion bodies were in the stomach without inflammation and encephalitis was without clinical signs. One of the highest titers of CDV in different organs of the three dogs was commonly systemic lymphatic organs, including the spleen, lymph nodes and tonsils. New isolates of CDV joined to the clades of the Asia 1 group that is far from the vaccine group. These results surely indicate that wild strains of CDV from dogs with a vaccination history were not reversed vaccine virus, and that the dogs showed characteristics of recent CD in Japan. 相似文献
16.
表达犬瘟热病毒H基因重组新城疫病毒的构建及其免疫原性研究 总被引：1，自引：0，他引：1
为研制安全、有效的新型犬瘟热疫苗,本研究利用新城疫病毒(NDV) LaSota弱毒疫苗株反向遗传操作系统,构建出表达犬瘟热病毒(CDV)弱毒疫苗株Rockborn-20/8血凝素(H)蛋白的重组病毒rLa-CDV-H,并对其生物学特性进行鉴定,评估其作为犬瘟热活载体疫苗的安全性和有效性.通过免疫荧光和western blot试验证明了CDV H蛋白的正确表达;重组病毒株保持了LaSota亲本株的低致病性和高滴度鸡胚生长特性;重组病毒rLa-CDV-H接种12周龄比格犬后,可以诱导显著的CDV中和抗体反应.本研究表明重组病毒rLa-CDV-H具有作为犬瘟热重组病毒活载体疫苗的潜力. 相似文献
17.
To examine how the inclusion (+) or exclusion (-) of inactivated Leptospira antigens in a vaccine for canine parvovirus type 2 (CPV-2), canine distemper virus (CDV) and canine adenovirus type 2 (CAdV-2) affects antibody titres to CPV-2, CDV and CAdV-1 antigens, household dogs were vaccinated with commercially available vaccines from one of three manufacturers. CPV-2, CDV and CAdV-1 antibody titres were measured 11 to 13 months later and compared within three different age groups and three different bodyweight groups. There were significant differences between CPV-2 antibody titres in dogs vaccinated with (+) vaccine and those vaccinated with (-) vaccine for two products in the two-year-old group and for one product in the greater than seven-year-old group; no significant differences were seen that could be attributed to bodyweight. No differences in CDV antibody titres were observed within age groups, but a significant difference was seen in the 11 to 20 kg weight group for one product. Significant differences in CAdV-1 antibody titres were seen for one product in both the two-year-old group and the ≤10 kg weight group. 相似文献
18.
为建立一种鉴别犬瘟热病毒(CDV)野毒株与疫苗株的反转录-环介导等温扩增方法(RT-LAMP),本研究通过比对野毒株与疫苗株H基因设计特异性引物,对反应体系中的Mg2+、Betaine、Bst DNA Polymerase、dNTP和反应温度等条件分别进行优化,建立用于鉴别检测CDV野毒株与疫苗株的RT-LAMP。建立的RT-LAMP方法检测CDV野毒株时,在65℃水浴锅中反应40 min即可完成。该方法具有高度特异性,对犬细小病毒、犬腺病毒、狂犬病毒、犬冠状病毒无交叉反应,敏感度可达40 copies/μL,是常规RT-PCR方法的100倍。 相似文献
19.
某大型猪场临床仔猪见不明原因腹泻,发病率高,而对妊娠母猪普遍接种ＴＧＥ和ＰＥＤ疫苗后收到了明显的防病效果。 相似文献
20.
Larson LJ Schultz RD 《Veterinary therapeutics : research in applied veterinary medicine》2006,7(2):113-118
Vaccination with modified-live virus (MLV) canine distemper virus (CDV) vaccine has historically been recommended for animals in high-risk environments because of the rapid onset of immunity following vaccination. Recombinant CDV (rCDV) vaccine was deemed a suitable alternative to MLV-CDV vaccination in pet dogs, but insufficient data precluded its use where CDV was a serious threat to puppies, such as in shelters, kennels, and pet stores. In this study, dogs experimentally challenged hours after a single dose of rCDV or MLV vaccine became sick but recovered, whereas unvaccinated dogs became sick and died. Dogs vaccinated with a single dose of rCDV or MLV vaccine 1 week before being experimentally challenged remained healthy and showed no clinical signs. Dogs given one dose of rCDV vaccine hours before being placed in a CDV-contaminated environment did not become sick. These findings support the hypothesis that rCDV vaccine has a similar time-to-immunity as MLV-CDV vaccines and can likewise protect dogs in high-risk environments after one dose. 相似文献